Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Green Cross HealthNZSE:GXH -0.25%63 Days Payable is 83.08 as of Mar. 2026, which is 44% above its 10-year median of 57.85. GuruFocus rates NZSE:GXH with a GF Score™ of 63/100 and a GF Value™ of NZ$1.08 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Green Cross Health ranks better than 61.32% on this metric.
The historical rank and industry rank for Green Cross Health's Days Payable or its related term are showing as below:
NZSE:GXH'
s Days Payable Range Over the Past 10 Years
Min: 52.47 Med: 57.85 Max: 76.25
Current: 76.25
During the past 13 years, Green Cross Health's highest Days Payable was 76.25. The lowest was 52.47. And the median was 57.85.
NZSE:GXH's Days Payable is ranked better than 61.32% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 56.95
vs NZSE:GXH: 76.25
Green Cross Health's Days Payable
declined
from Mar. 2025 (85.06) to Mar. 2026 (83.08).
It may suggest that Green Cross Healthaccelerated paying its suppliers.
The historical data trend for Green Cross Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Green Cross Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Cross Health Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Green Cross Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Green Cross Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Green Cross Health's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health (NZSE:GXH) has a Days Payable of 83.08 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Green Cross Health and its competitors. This is 44% above median its historical median of 57.85. Over the past decade, Green Cross Health's Days Payable has ranged from 52.47 to 76.25. According to the industry distribution chart, Green Cross Health ranks #234 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 38.7%.
Is Green Cross Health's Days Payable too high?
Green Cross Health's current Days Payable of 83.08 is 44% above median its 10-year median of 57.85. Over the past 10 years, this metric has ranged from a low of 52.47 to a high of 76.25. The Healthcare Providers & Services industry median Days Payable is 56.95. Green Cross Health's value of 83.08 is 45.9% above this industry median. Based on the distribution chart, Green Cross Health ranks #234 out of 605 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Green Cross Health has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Cross Health's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Green Cross Health ranks #234 out of 605 companies for Days Payable. This puts Green Cross Health in the upper half of its industry. The industry median Days Payable is 56.95. Green Cross Health's value of 83.08 is 45.9% above this benchmark. Historically, Green Cross Health's own Days Payable has ranged from 52.47 to 76.25 over the past decade. While the company's 10-year median is 57.85 vs. the industry median of 56.95, Green Cross Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.95, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Cross Health's current Days Payable of 83.08 is 45.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Green Cross Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Cross Health's current Days Payable is 83.08, which is 44% above median its own 10-year median of 57.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Cross Health stock overvalued right now?
Based on GuruFocus' analysis, Green Cross Health (NZSE:GXH) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$1.08, compared to a current price of NZ$1.96 — trading 81.5% above its estimated fair value. The current Days Payable is 83.08, which is 44% above median its 10-year median of 57.85 and 45.9% above the Healthcare Providers & Services industry median of 56.95. Green Cross Health's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Green Cross Health (NZSE:GXH), the current Days Payable is 83.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Cross Health (NZSE:GXH) Overvalued in 2026?
Based on GuruFocus' analysis, Green Cross Health stock appears to be overvalued.
The current stock price of NZ$1.96 is trading 81.5% above its estimated GF Value™ of NZ$1.08.
GuruFocus considers Green Cross Health to be Significantly Overvalued.
Key valuation signals for NZSE:GXH:
Days Payable: 83.08 (44% above median its 10-year median of 57.85)
GF Value™: NZ$1.08 vs. price of NZ$1.96 (81.5% above fair value)
Industry Position: 45.9% above the Healthcare Providers & Services median (#234 of 605)
No single metric tells the full story. See the NZSE:GXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. The pharmacy services segment provides retail and dispensary services, and the medical services segment provides GP, nursing, and urgent care services. The majority of its revenue is generated from the pharmacy segment.
63GF Score
Get the complete analysis for NZSE:GXH
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:GXH has been successfully added to your 
